Radiopharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change Including: 1) By Type: Diagnostic; Therapeutic 2) By Application: Oncology; Cardiology; Neuroendocrinology; Nephrology; Musculoskeletal; Respiratory; Other
Description
Radiopharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global radiopharmaceuticals market as it emerges from the COVID 19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:
Where is the largest and fastest growing market for radiopharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The radiopharmaceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider radiopharmaceuticals market; and compares it with other markets.
The report covers the following chapters
Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, segmentation by application and segmentation by end-user.
Market Characteristics – The market characteristics section of the report defines and explains the radiopharmaceuticals market. This chapter also defines and describes goods and related services covered in the report.
Trends And Strategies – This chapter describes the major trends shaping the global radiopharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Impact of COVID-19 – This section describes the impact of COVID-19 on the radiopharmaceuticals market.
Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
Competitive Landscape – This section covers details on the competitive landscape of the global radiopharmaceuticals market, estimated market shares and company profiles for the leading players.
Radiopharmaceuticals Pipeline Analysis – This chapter gives the information on radiopharmaceuticals pipeline analysis.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for radiopharmaceutical companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered: 1) By Type: Diagnostic; Therapeutic
2) By Application: Oncology; Cardiology; Neuroendocrinology; Nephrology; Musculoskeletal; Respiratory; Others
3) By End-User: Hospitals And Ambulatory Surgical Centers; Diagnostic Centers; Cancer Research Institutes
Companies Mentioned: Cardinal Health; Curium Pharma; Siemens Healthineers AG; Novartis AG; General Electric Company (GE)
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; radiopharmaceuticals indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:
Where is the largest and fastest growing market for radiopharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The radiopharmaceuticals market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider radiopharmaceuticals market; and compares it with other markets.
The report covers the following chapters
Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, segmentation by application and segmentation by end-user.
Market Characteristics – The market characteristics section of the report defines and explains the radiopharmaceuticals market. This chapter also defines and describes goods and related services covered in the report.
Trends And Strategies – This chapter describes the major trends shaping the global radiopharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Impact of COVID-19 – This section describes the impact of COVID-19 on the radiopharmaceuticals market.
Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
Competitive Landscape – This section covers details on the competitive landscape of the global radiopharmaceuticals market, estimated market shares and company profiles for the leading players.
Radiopharmaceuticals Pipeline Analysis – This chapter gives the information on radiopharmaceuticals pipeline analysis.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for radiopharmaceutical companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered: 1) By Type: Diagnostic; Therapeutic
2) By Application: Oncology; Cardiology; Neuroendocrinology; Nephrology; Musculoskeletal; Respiratory; Others
3) By End-User: Hospitals And Ambulatory Surgical Centers; Diagnostic Centers; Cancer Research Institutes
Companies Mentioned: Cardinal Health; Curium Pharma; Siemens Healthineers AG; Novartis AG; General Electric Company (GE)
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; radiopharmaceuticals indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
265 Pages
- 1. Radiopharmaceuticals Market Executive Summary
- 2. Table of Contents
- 3. List of Figures
- 4. List of Tables
- 5. Report Structure
- 6. Introduction
- 6.1. Segmentation By Geography
- 6.2. Segmentation By Type
- 6.3. Segmentation By Application
- 6.4. Segmentation By End User
- 7. Radiopharmaceuticals Market Characteristics
- 7.1. Market Definition
- 7.2. Segmentation By Type
- 7.2.1. Diagnostic
- 7.2.2. Therapeutic
- 7.3. Segmentation By Application
- 7.3.1. Oncology
- 7.3.2. Cardiology
- 7.3.3. Musculoskeletal
- 7.3.4. Neuroendocrinology
- 7.3.5. Respiratory
- 7.3.6. Nephrology
- 7.3.7. Others
- 7.4. Segmentation By End-User
- 7.4.1. Hospitals And Ambulatory Surgical Centers
- 7.4.2. Diagnostic Centers
- 7.4.3. Cancer Research Institutes
- 8. Radiopharmaceuticals Market Trends And Strategies
- 8.1. Research Collaborations And Partnerships
- 8.2. Plant Capacity Expansion
- 8.3. 3D Printing Technology
- 8.4. Technological Developments
- 8.5. Investments In Innovation
- 8.6. In Silico Modeling
- 8.7. Investment In Artificial Intelligence
- 8.8. Dominance of Cardiology
- 8.9. Radiopharmaceutical Cancer Therapy
- 9. Impact Of COVID-19 On The Radiopharmaceuticals Market
- 9.1. Introduction
- 9.2. Impact On Laboratories And Procedures
- 9.3. Impact On Inpatient And Outpatient Radiopharmaceutical Operations
- 9.4. Supply and Demand Disruptions
- 9.5. Conclusion
- 10. Global Radiopharmaceuticals Market Size And Growth
- 10.1. Market Size
- 10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)
- 10.2.1. Drivers Of The Market 2015 – 2020
- 10.2.2. Restraints On The Market 2015 – 2020
- 10.3.Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 10.3.1. Drivers Of The Market 2020 – 2025
- 10.3.2. Restraints On The Market 2020 – 2025
- 11. Global Radiopharmaceuticals Market Segmentation
- 11.1. Global Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 11.2. Global Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 11.3. Global Radiopharmaceuticals Market, Segmentation By End User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 12. Radiopharmaceuticals Market, Regional And Country Analysis
- 12.1. Global Radiopharmaceuticals Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 12.1.1. North America
- 12.1.2. Asia Pacific
- 12.1.3. Africa
- 12.2. Global Radiopharmaceuticals Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 12.2.1. USA
- 12.2.2. China
- 13. Asia-Pacific Radiopharmaceuticals Market
- 13.1. Asia-Pacific Radiopharmaceuticals Market Overview
- 13.1.1. Region Information
- 13.1.2. Market Information
- 13.1.3. Background Information
- 13.1.4. Government Initiatives
- 13.1.5. Regulations
- 13.1.6. Regulatory Bodies
- 13.1.7. Major Associations
- 13.1.8. Taxes Levied
- 13.1.9. Corporate Tax Structure
- 13.1.10. Investments
- 13.1.11. Major Companies
- 13.2. Asia-Pacific Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.3. Asia-Pacific Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 13.4.Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.5. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.6.Asia-Pacific Radiopharmaceuticals Market: Country Analysis
- 13.7. China Radiopharmaceuticals Market
- 13.8.China Radiopharmaceuticals Market Overview
- 13.8.1. Country Information
- 13.8.2. Market Information
- 13.8.3. Background Information
- 13.8.4. Government Initiatives
- 13.8.5. Regulations
- 13.8.6. Regulatory Bodies
- 13.8.7. Major Associations
- 13.8.8. Taxes Levied
- 13.8.9. Corporate Tax Structure
- 13.8.10. Investments
- 13.8.11. Major Companies
- 13.9.China Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.10. China Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 13.11. China Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.12. China Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.13. India Radiopharmaceuticals Market
- 13.14. India Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.15. India Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 13.16. India Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.17. India Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.18. Japan Radiopharmaceuticals Market
- 13.19. Japan Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.20. Japan Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 13.21. Japan Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.22. Japan Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.23. Australia Radiopharmaceuticals Market
- 13.24. Australia Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.25. Australia Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 13.26. Australia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.27. Australia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.28. Indonesia Radiopharmaceuticals Market
- 13.29. Indonesia Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.30. Indonesia Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 13.31. Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.32. Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.33. South Korea Radiopharmaceuticals Market
- 13.34. South Korea Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 13.35. South Korea Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 13.36. South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 13.37. South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14. Western Europe Radiopharmaceuticals Market
- 14.1.Western Europe Radiopharmaceuticals Market Overview
- 14.1.1. Region Information
- 14.1.2. Market Information
- 14.1.3. Background Information
- 14.1.4. Government Initiatives
- 14.1.5. Regulations
- 14.1.6. Regulatory Bodies
- 14.1.7. Major Associations
- 14.1.8. Taxes Levied
- 14.1.9. Corporate Tax Structure
- 14.1.10. Investments
- 14.1.11. Major Companies
- 14.2. Western Europe Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 14.3.Western Europe Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 14.4. Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.5. Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.6. Western Europe Radiopharmaceuticals Market: Country Analysis
- 14.7. UK Radiopharmaceuticals Market
- 14.8. UK Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 14.9. UK Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 14.10. UK Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.11. UK Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.12. Germany Radiopharmaceuticals Market
- 14.13. Germany Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 14.14. Germany Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 14.15. Germany Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.16. Germany Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.17. France Radiopharmaceuticals Market
- 14.18. France Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 14.19. France Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 14.20. France Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 14.21. France Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 15. Eastern Europe Radiopharmaceuticals Market
- 15.1. Eastern Europe Radiopharmaceuticals Market Overview
- 15.1.1. Region Information
- 15.1.2. Market Information
- 15.1.3. Background Information
- 15.1.4. Government Initiatives
- 15.1.5. Regulations
- 15.1.6. Regulatory Bodies
- 15.1.7. Major Associations
- 15.1.8. Taxes Levied
- 15.1.9. Corporate Tax Structure
- 15.1.10. Investments
- 15.1.11. Major Companies
- 15.2. Eastern Europe Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 15.3. Eastern Europe Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 15.4. Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 15.5. Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 15.6. Eastern Europe Radiopharmaceuticals Market: Country Analysis
- 15.7. Russia Radiopharmaceuticals Market
- 15.8. Russia Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 15.9. Russia Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 15.10. Russia Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 15.11. Russia Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 16. North America Radiopharmaceuticals Market
- 16.1.North America Radiopharmaceuticals Market Overview
- 16.1.1. Region Information
- 16.1.2. Market Information
- 16.1.3. Background Information
- 16.1.4. Government Initiatives
- 16.1.5. Regulations
- 16.1.6. Regulatory Bodies
- 16.1.7. Major Associations
- 16.1.8. Taxes Levied
- 16.1.9. Corporate Tax Structure
- 16.1.10. Investments
- 16.1.11. Major Companies
- 16.2. North America Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 16.3.North America Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 16.4. North America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 16.5. North America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 16.6. North America Radiopharmaceuticals Market: Country Analysis
- 16.7. USA Radiopharmaceuticals Market
- 16.8. USA Radiopharmaceuticals Market Overview
- 16.8.1. Country Information
- 16.8.2. Market Information
- 16.8.3. Background Information
- 16.8.4. Government Initiatives
- 16.8.5. Regulations
- 16.8.6. Regulatory Bodies
- 16.8.7. Major Associations
- 16.8.8. Taxes Levied
- 16.8.9. Corporate Tax Structure
- 16.8.10.Investments
- 16.8.11. Major Companies
- 16.9. USA Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 16.10. USA Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 16.11. USA Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 16.12. USA Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 17. South America Radiopharmaceuticals Market
- 17.1. South America Radiopharmaceuticals Market Overview
- 17.1.1. Region Information
- 17.1.2. Market Information
- 17.1.3. Background Information
- 17.1.4. Government Initiatives
- 17.1.5. Regulations
- 17.1.6. Regulatory Bodies
- 17.1.7. Associations
- 17.1.8. Taxes Levied
- 17.1.9. Corporate Tax Structure
- 17.1.10. Investments
- 17.1.11. Major Companies
- 17.2. South America Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 17.3. South America Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 17.4. South America Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 17.5. South America Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 17.6. South America Radiopharmaceuticals Market: Country Analysis
- 17.7. Brazil Radiopharmaceuticals Market
- 17.8. Brazil Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 17.9. Brazil Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 17.10. Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 17.11. Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 18. Middle East Radiopharmaceuticals Market
- 18.1. Middle East Radiopharmaceuticals Market Overview
- 18.1.1. Region Information
- 18.1.2. Market Information
- 18.1.3. Background Information
- 18.1.4. Government Initiatives
- 18.1.5. Regulations
- 18.1.6. Regulatory Bodies
- 18.1.7. Major Associations
- 18.1.8. Taxes Levied
- 18.1.9. Investments
- 18.1.10. Major Companies
- 18.2. Middle East Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 18.3.Middle East Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 18.4. Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 18.5. Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 19. Africa Radiopharmaceuticals Market
- 19.1.Africa Radiopharmaceuticals Market Overview
- 19.1.1. Region Information
- 19.1.2. Market Information
- 19.1.3. Background Information
- 19.1.4. Government Initiatives
- 19.1.5. Regulations
- 19.1.6. Regulatory Bodies
- 19.1.7. Major Associations
- 19.1.8. Taxes levied
- 19.1.9. Investments
- 19.1.10. Major Companies
- 19.2. Africa Radiopharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
- 19.3.Africa Radiopharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
- 19.4. Africa Radiopharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 19.5. Africa Radiopharmaceuticals Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
- 20. Global Radiopharmaceuticals Market Competitive Landscape
- 20.1. Company Profiles
- 20.2. Cardinal Health
- 20.2.1. Company Overview
- 20.2.2. Products And Services
- 20.2.3. Business Strategy
- 20.2.4. Financial Overview
- 20.3. Curium Pharma
- 20.3.1. Company Overview
- 20.3.2. Products And Services
- 20.3.3. Business Strategy
- 20.3.4. Financial Overview
- 20.4. Siemens Healthineers AG
- 20.4.1. Company Overview
- 20.4.2. Products And Services
- 20.4.3. Business Strategy
- 20.4.4. Financial Overview
- 20.5. Novartis AG
- 20.5.1. Company Overview
- 20.5.2. Products And Services
- 20.5.3. Business Strategy
- 20.5.4. Financial Overview
- 20.6. General Electric Company (GE)
- 20.6.1. Company Overview
- 20.6.2. Products And Services
- 20.6.3. Business Strategy
- 20.6.4. Financial Overview
- 21. Radiopharmaceuticals Market Pipeline Analysis
- 22. Key Mergers And Acquisitions In The Radiopharmaceuticals Market
- 22.1. Bayer Acquired Noria Therapeutics And PSMA Therapeutics
- 22.2. Curium Acquired MAP Medical Technologies Oy
- 22.3. ISOLOGIC Acquired Diagnostic FDG Distribution From CPDC
- 22.4. TTG Imaging Solutions Acquired NISotopes
- 22.5. Curium Acquired MAP Medical Technologies Oy
- 22.6. Progenics Acquired Orphan Radiopharmaceuticals
- 22.7. Novartis Acquired Endocyte
- 22.8. Jubilant Pharma Acquired Triad Isotopes
- 22.9. Pharmalogic Acquired Radiopharmacy of Paducah
- 22.10. IBA Molecular Acquired Mallinckrodt Nuclear Imaging
- 23. Global Radiopharmaceuticals Market Opportunities And Strategies
- 23.1. Global Radiopharmaceuticals Market In 2025 – Countries Offering Most New Opportunities
- 23.2. Global Radiopharmaceuticals Market In 2025 – Segments Offering Most New Opportunities
- 23.3.Global Radiopharmaceuticals Market In 2025 – Growth Strategies
- 23.3.1. Market Trend Based Strategies
- 23.3.2. Competitor Strategies
- 24. Radiopharmaceuticals Market, Conclusions And Recommendations
- 24.1. Conclusions
- 24.2. Recommendations
- 24.2.1. Product
- 24.2.2. Place
- 24.2.3. Price
- 24.2.4. Promotion
- 24.2.5. People
- 25. Appendix
- 25.1. Market Data Sources
- 25.2. Research Methodology
- 25.3. Currencies
- 25.4. Research Inquiries
- 25.5. The Business Research Company
- 25.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.